OXY Rapid Spot Treatment

Manufacturer: The Mentholatum Company
Effective date: 2024-01-23
Label type: HUMAN OTC DRUG LABEL
Version: 4
Source: full-release
Hydrated at: 2026-06-01 00:42:44

Label at a glance#

ProductOXY Rapid Spot Treatment Maximum Action

Active ingredientBENZOYL PEROXIDE

Label structure8 sections

Indications and uses

treats and helps prevent acne

Dosage and administration

clean skin thoroughly before applying this product cover entire affected area with a thin layer 1 to 3 times daily because excessive drying of the skin may occur, start with 1 application daily, then gradually increase to 2 or 3 times daily if needed or as directed by a doctor if bothersome dryness or peeling occurs, reduce application to once a day or every other day if going outside, apply sunscreen after using ...

Label contents#

Full prescribing information#

Active ingredient

OTC - ACTIVE INGREDIENT SECTION

Benzoyl peroxide 10%

Purpose

OTC - PURPOSE SECTION

Acne treatment

Uses

INDICATIONS & USAGE SECTION

treats and helps prevent acne

Warnings

WARNINGS SECTION

For external use only

Do Not Use if you

OTC - DO NOT USE SECTION

have very sensitive skin
are sensitive to benzoyl peroxide

When using this product

OTC - WHEN USING SECTION

skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time.
avoid unnecessary sun exposure and use a sunscreen
avoid contact with the eyes, lips, and mouth
avoid contact with hair and dyed fabrics, which may be bleached by this product
skin irritation may occur, characterized by redness, burning, itching, peeling, or possibly swelling. Irritation may be reduced by using this product less frequently or in a lower concentration.

Stop use and ask a doctor if

OTC - STOP USE SECTION

irritation becomes severe

If pregnant or breast-feeding

OTC - PREGNANCY OR BREAST FEEDING SECTION

Ask a health professional before use.

Keep Out of Reach of Children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

clean skin thoroughly before applying this product
cover entire affected area with a thin layer 1 to 3 times daily
because excessive drying of the skin may occur, start with 1 application daily, then gradually increase to 2 or 3 times daily if needed or as directed by a doctor
if bothersome dryness or peeling occurs, reduce application to once a day or every other day
if going outside, apply sunscreen after using this product. If irritation or sensitivity develops, stop use of both products and ask a doctor.
Sensitivity Test: Apply product sparingly to a small affected area for the first 3 days. If no discomfort occurs, follow directions above.

Inactive Ingredients

INACTIVE INGREDIENT SECTION

anhydrous citric acid, butylene glycol, carbomer homopolymer, diazolidinyl urea, dimethicone, dimethyl isosorbide, edetate disodium, fragrance, glycerin, hydrolyzed soy protein, iodopropynyl butylcarbamate, lauryl methacrylate/glycol dimethacrylate crosspolymer, PEG/PPG-4/12 dimethicone, portulaca oleracea extract, propylene glycol, purified water, silica, sodium citrate, sodium hydroxide, xanthan gum

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Oxy Image

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	SPL version
106315	benzoyl peroxide 10 % Topical Cream	PSN	4
106315	benzoyl peroxide 100 MG/ML Topical Cream	SCD	4
106315	benzoyl peroxide 10 % Topical Cream	SY	4

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
a46239a7-5963-4008-8cbb-6b9000f497eb	Product name	1	20250721
b382b4e1-6b48-45f6-bffc-e61b00b0ce19	Product name	3	20250317
e2db08c6-133f-4f4f-afb4-e90a2418d6f6	Product name	1	20230320
d9d61457-6a5a-41fc-b418-e5479a2904b7	Product name	2	20230303
32012d5c-25ac-49c7-9d4c-1313177fff7c	Product name	1	20230112
13e7e7e3-e885-4c79-af6d-dad1aedbb06e	Product name	1	20220128
4a7d44fe-774d-404b-aad0-8a90fe78375a	Product name	4	20211025
ce6d5c06-3ae0-18a6-d5b3-8cd3cc0f8906	Product name	7	20210625
f52be47f-7aa7-46c0-b1fa-50c18dd50206	Product name	1	20201029
3f45980c-c196-47e5-0e5e-48b7c57327c5	Product name	5	20200428
d12e2d7c-bd6b-45d4-94f9-6df8e1b8b27b	Product name	3	20200203
ee5c6de5-d9cd-454f-b250-7b19e5cf2992	Product name	4	20190619
11ed6f83-cdd2-4637-8379-b1a1d3ae3cde	Product name	1	20181101
86c45a79-b9f0-4476-a27c-6e10db098497	Product name	1	20180125
ad75fcfd-a339-42a1-9c60-43ba2c654cfa	Product name	1	20170810
d5e51f11-ad28-caa4-4b49-4143974782ad	Product name	1	20150831

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
10742-1301-1	2023-02-07	C162847	48780-1	f386c649-a383-0266-e053-dadaa90a7c1a	Drug Facts - OXY Rapid Spot Treatment
10742-1301-1	2023-01-30	C162847	48780-1	f386c649-a383-0266-e053-dadaa90a7c1a	Drug Facts - OXY Rapid Spot Treatment

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
10742-1301-1	OXY Rapid Spot TreatmentMaximum Action	28 g in 1 TUBE	CREAM	28		4
10742-1301-1	OXY Rapid Spot TreatmentMaximum Action	1 in 1 CARTON	CREAM	1		4

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
10742-1301	OXY RAPID SPOT TREATMENT MAXIMUM ACTION (BENZOYL PEROXIDE) CREAM [THE MENTHOLATUM COMPANY]	4	Current NDC, Legacy NDC, 2 package rows	20241215_226dad56-e415-41ec-937a-4282c73f0d34.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
BENZOYL PEROXIDE	ACTIVE INGREDIENT	W9WZN9A0GM	1
BENZOYL PEROXIDE	ACTIVE MOIETY	W9WZN9A0GM	1
ANHYDROUS CITRIC ACID	INACTIVE INGREDIENT	XF417D3PSL	1
BUTYLENE GLYCOL	INACTIVE INGREDIENT	3XUS85K0RA	1
CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED)	INACTIVE INGREDIENT	4Q93RCW27E	1
DIAZOLIDINYL UREA	INACTIVE INGREDIENT	H5RIZ3MPW4	1
DIMETHICONE	INACTIVE INGREDIENT	92RU3N3Y1O	1
DIMETHYL ISOSORBIDE	INACTIVE INGREDIENT	SA6A6V432S	1
EDETATE DISODIUM	INACTIVE INGREDIENT	7FLD91C86K	1
GLYCERIN	INACTIVE INGREDIENT	PDC6A3C0OX	1
IODOPROPYNYL BUTYLCARBAMATE	INACTIVE INGREDIENT	603P14DHEB	1
LAURYL METHACRYLATE/GLYCOL DIMETHACRYLATE CROSSPOLYMER	INACTIVE INGREDIENT	EX0F4CZ66H	1
PEG/PPG-4/12 DIMETHICONE	INACTIVE INGREDIENT	JAN3585W85	1
PROPYLENE GLYCOL	INACTIVE INGREDIENT	6DC9Q167V3	1
PURSLANE	INACTIVE INGREDIENT	M6S840WXG5	1
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	1
SODIUM CITRATE	INACTIVE INGREDIENT	1Q73Q2JULR	1
SODIUM HYDROXIDE	INACTIVE INGREDIENT	55X04QC32I	1
SOY PROTEIN	INACTIVE INGREDIENT	R44IWB3RN5	1
WATER	INACTIVE INGREDIENT	059QF0KO0R	1
XANTHAN GUM	INACTIVE INGREDIENT	TTV12P4NEE	1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 21 matching rows.

OXY Rapid Spot Treatment Maximum Action
benzoyl peroxide
ANHYDROUS CITRIC ACID
BUTYLENE GLYCOL
CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED)
DIAZOLIDINYL UREA
DIMETHICONE
DIMETHYL ISOSORBIDE
EDETATE DISODIUM
GLYCERIN
SOY PROTEIN
IODOPROPYNYL BUTYLCARBAMATE
LAURYL METHACRYLATE/GLYCOL DIMETHACRYLATE CROSSPOLYMER
PEG/PPG-4/12 DIMETHICONE
PURSLANE
PROPYLENE GLYCOL
WATER
SILICON DIOXIDE
SODIUM CITRATE, UNSPECIFIED FORM
SODIUM HYDROXIDE
XANTHAN GUM

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
10742-1301	10742-1301-1

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 20 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
ANHYDROUS CITRIC ACID	XF417D3PSL	IACT
BUTYLENE GLYCOL	3XUS85K0RA	IACT
CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED)	4Q93RCW27E	IACT
DIAZOLIDINYL UREA	H5RIZ3MPW4	IACT
DIMETHICONE	92RU3N3Y1O	IACT
DIMETHYL ISOSORBIDE	SA6A6V432S	IACT
EDETATE DISODIUM	7FLD91C86K	IACT
GLYCERIN	PDC6A3C0OX	IACT
SOY PROTEIN	R44IWB3RN5	IACT
IODOPROPYNYL BUTYLCARBAMATE	603P14DHEB	IACT
LAURYL METHACRYLATE/GLYCOL DIMETHACRYLATE CROSSPOLYMER	EX0F4CZ66H	IACT
PEG/PPG-4/12 DIMETHICONE	JAN3585W85	IACT
PURSLANE	M6S840WXG5	IACT
PROPYLENE GLYCOL	6DC9Q167V3	IACT
WATER	059QF0KO0R	IACT
SILICON DIOXIDE	ETJ7Z6XBU4	IACT
SODIUM CITRATE, UNSPECIFIED FORM	1Q73Q2JULR	IACT
SODIUM HYDROXIDE	55X04QC32I	IACT
XANTHAN GUM	TTV12P4NEE	IACT
BENZOYL PEROXIDE	W9WZN9A0GM	ACTIB

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 24 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	CREAM / TOPICAL		69 mg	Exact identifier — unii+route+dosage form 2 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	CREAM / VAGINAL		51 mg	Exact identifier — unii+dosage form 4 equally ranked IID candidates
DIAZOLIDINYL UREA	DIAZOLIDINYL UREA	H5RIZ3MPW4	CREAM / TOPICAL		29 mg	Exact identifier — unii+route+dosage form 2 equally ranked IID candidates
DIMETHYL ISOSORBIDE	DIMETHYL ISOSORBIDE	SA6A6V432S	CREAM / TOPICAL	15 %w/w		Exact identifier — unii+route+dosage form 2 equally ranked IID candidates
ANHYDROUS CITRIC ACID	ANHYDROUS CITRIC ACID	XF417D3PSL	CREAM / TOPICAL		1 mg	Exact identifier — unii+route+dosage form 2 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	CREAM / TOPICAL		76000 mg	Exact identifier — unii+route+dosage form 2 equally ranked IID candidates
XANTHAN GUM	XANTHAN GUM	TTV12P4NEE	CREAM / TOPICAL		46 mg	Exact identifier — unii+route+dosage form 2 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	CREAM / TOPICAL		76000 mg	Exact identifier — unii+route+dosage form 2 equally ranked IID candidates
BUTYLENE GLYCOL	BUTYLENE GLYCOL	3XUS85K0RA	SYSTEM / TOPICAL		1400 mg	Exact identifier — unii+route 2 equally ranked IID candidates
DIAZOLIDINYL UREA	DIAZOLIDINYL UREA	H5RIZ3MPW4	CREAM / TOPICAL		29 mg	Exact identifier — unii+route+dosage form 2 equally ranked IID candidates
BUTYLENE GLYCOL	BUTYLENE GLYCOL	3XUS85K0RA	SYSTEM / TOPICAL		1400 mg	Exact identifier — unii+route 2 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	GEL / TOPICAL		6 mg	Exact identifier — unii+route 4 equally ranked IID candidates
EDETATE DISODIUM	EDETATE DISODIUM	7FLD91C86K	CREAM / TOPICAL		14 mg	Exact identifier — unii+route+dosage form 2 equally ranked IID candidates
ANHYDROUS CITRIC ACID	ANHYDROUS CITRIC ACID	XF417D3PSL	CREAM / TOPICAL		1 mg	Exact identifier — unii+route+dosage form 2 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	GEL / TOPICAL		6 mg	Exact identifier — unii+route 4 equally ranked IID candidates
CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED)	CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED)	4Q93RCW27E	CREAM / TOPICAL		103 mg	Exact identifier — unii+route+dosage form 2 equally ranked IID candidates
GLYCERIN	GLYCERIN	PDC6A3C0OX	CREAM / TOPICAL		1720 mg	Exact identifier — unii+route+dosage form 2 equally ranked IID candidates
GLYCERIN	GLYCERIN	PDC6A3C0OX	CREAM / TOPICAL		1720 mg	Exact identifier — unii+route+dosage form 2 equally ranked IID candidates
XANTHAN GUM	XANTHAN GUM	TTV12P4NEE	CREAM / TOPICAL		46 mg	Exact identifier — unii+route+dosage form 2 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	CREAM / VAGINAL		51 mg	Exact identifier — unii+dosage form 4 equally ranked IID candidates
EDETATE DISODIUM	EDETATE DISODIUM	7FLD91C86K	CREAM / TOPICAL		14 mg	Exact identifier — unii+route+dosage form 2 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	CREAM / TOPICAL		69 mg	Exact identifier — unii+route+dosage form 2 equally ranked IID candidates
DIMETHYL ISOSORBIDE	DIMETHYL ISOSORBIDE	SA6A6V432S	CREAM / TOPICAL	15 %w/w		Exact identifier — unii+route+dosage form 2 equally ranked IID candidates
CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED)	CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED)	4Q93RCW27E	CREAM / TOPICAL		103 mg	Exact identifier — unii+route+dosage form 2 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
OXY Rapid Spot Treatment Maximum Action	BENZOYL PEROXIDE	The Mentholatum Company	226dad56-e415-41ec-937a-4282c73f0d34	2024-01-23	Warnings	Exact identifier ndc (package): 10742-1301-1 ndc (product): 10742-1301 ndc11 (package): 10742130101 spl id: 0fa156ef-27f6-0ac8-e063-6294a90af15f spl set id: 226dad56-e415-41ec-937a-4282c73f0d34

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.